EP1267934A4 - Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein - Google Patents

Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein

Info

Publication number
EP1267934A4
EP1267934A4 EP00980657A EP00980657A EP1267934A4 EP 1267934 A4 EP1267934 A4 EP 1267934A4 EP 00980657 A EP00980657 A EP 00980657A EP 00980657 A EP00980657 A EP 00980657A EP 1267934 A4 EP1267934 A4 EP 1267934A4
Authority
EP
European Patent Office
Prior art keywords
staging
diagnosing
imaging
monitoring
breast cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00980657A
Other languages
German (de)
English (en)
Other versions
EP1267934A2 (fr
Inventor
Susana Salceda
Robert Cafferkey
Herve Recipon
Yongming Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of EP1267934A2 publication Critical patent/EP1267934A2/fr
Publication of EP1267934A4 publication Critical patent/EP1267934A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP00980657A 1999-11-23 2000-11-22 Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein Withdrawn EP1267934A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16697399P 1999-11-23 1999-11-23
US166973P 1999-11-23
PCT/US2000/032056 WO2001037779A2 (fr) 1999-11-23 2000-11-22 Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein

Publications (2)

Publication Number Publication Date
EP1267934A2 EP1267934A2 (fr) 2003-01-02
EP1267934A4 true EP1267934A4 (fr) 2004-03-17

Family

ID=22605420

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00980657A Withdrawn EP1267934A4 (fr) 1999-11-23 2000-11-22 Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein

Country Status (4)

Country Link
EP (1) EP1267934A4 (fr)
JP (1) JP2003526342A (fr)
CA (1) CA2390802A1 (fr)
WO (1) WO2001037779A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6844325B2 (en) 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6573368B2 (en) 1998-12-28 2003-06-03 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6590076B1 (en) 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6518237B1 (en) 1998-12-28 2003-02-11 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6586572B2 (en) 1998-12-28 2003-07-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6780586B1 (en) 1999-11-29 2004-08-24 Protein Design Labs, Inc. Methods of diagnosing breast cancer
AU1807401A (en) 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
EP1576113A4 (fr) * 2002-07-03 2010-08-18 Aventis Pasteur Inc Antigenes tumoraux bfa4 et bcy1 servant a prevenir et/ou a traiter le cancer
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer
GB0320648D0 (en) * 2003-09-03 2003-10-01 Randox Lab Ltd Molecular marker

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006776A1 (fr) * 1998-07-28 2000-02-10 Axys Pharmaceuticals, Inc. Etablissement du genotype de genes humains de l'udp-glucoronosyl-transferase 2b4 (ugt2b4), 2b7 (ugt2b7) et 2b15 (ugt2b15)
WO2000008210A1 (fr) * 1998-08-04 2000-02-17 Diadexus Llc Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter
WO2000055629A2 (fr) * 1999-03-15 2000-09-21 Eos Biotechnology, Inc. Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033915A1 (fr) * 1997-02-03 1998-08-06 Human Genome Sciences, Inc. Gene 1 specifique du cancer du sein

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006776A1 (fr) * 1998-07-28 2000-02-10 Axys Pharmaceuticals, Inc. Etablissement du genotype de genes humains de l'udp-glucoronosyl-transferase 2b4 (ugt2b4), 2b7 (ugt2b7) et 2b15 (ugt2b15)
WO2000008210A1 (fr) * 1998-08-04 2000-02-17 Diadexus Llc Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter
WO2000055629A2 (fr) * 1999-03-15 2000-09-21 Eos Biotechnology, Inc. Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE SWISSPROT [online] 1 January 1994 (1994-01-01), JIN, C.-J. ET AL.: "cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily", XP002267171, accession no. p36537 *
JIN C_J ET AL: "cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 194, no. 1, 15 July 1993 (1993-07-15), pages 496 - 503, XP002121839, ISSN: 0006-291X *

Also Published As

Publication number Publication date
EP1267934A2 (fr) 2003-01-02
CA2390802A1 (fr) 2001-05-31
WO2001037779A2 (fr) 2001-05-31
JP2003526342A (ja) 2003-09-09
WO2001037779A3 (fr) 2002-03-21

Similar Documents

Publication Publication Date Title
EP1105528A4 (fr) Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter
EP1239874A4 (fr) Methode de diagnostic, de controle, de stadification, d'imagerie et de traitement du cancer de la prostate
MXPA01008794A (es) Metodo para diagnosticar y verificar carcinomas de pecho malignos.
EP1267934A4 (fr) Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein
EP1082459A4 (fr) Technique de diagnostic, de suivi et de stadification du cancer du poumon
HK1040899A1 (en) Method for improved imaging and photodynamic therapy
IL138566A0 (en) Method and apparatus for motion-free cardiac ct imaging
EP1131095A4 (fr) Methode permettant de diagnostiquer, de surveiller, de classer par stades, de visualiser et de traiter le cancer de la prostate
EP1146912A4 (fr) Procedes et agents destines a une radiotherapie amelioree
HU9900386D0 (en) Method for treating heart failure
IL142340A0 (en) Methods for identification, diagnosis, and treatment of breast cancer
EP1107798A4 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer du colon
EP1104486A4 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
AU5947701A (en) Methods for identification, diagnosis, and treatment of breast cancer
AU2002348297A8 (en) Proteonomic methods for diagnosis and monitoring of breast cancer
GB2355385B (en) Breast measuring method and apparatus
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
EP1082460A4 (fr) Nouveau procede de diagnostic, de surveillance et de stadification du cancer de la prostate
EP1380840A4 (fr) Procede de diagnostic de cancer du sein
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
NO20014805L (no) Blandinger og fremgangsmater for behandling og diagnose av brystkreft
EP1117833A4 (fr) Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux
AU2001241656A1 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
EP1126877A4 (fr) Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate
EP1227841A4 (fr) Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020624

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 35/00 B

Ipc: 7A 61K 39/44 B

Ipc: 7A 61K 38/00 B

Ipc: 7C 07K 14/07 B

Ipc: 7A 61K 39/40 B

Ipc: 7A 61K 39/395 B

Ipc: 7C 12Q 1/68 B

Ipc: 7A 61K 47/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040130

17Q First examination report despatched

Effective date: 20040323

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060506